Dorzolamide and corneal recovery from edema in patients with glaucoma or ocular hypertension

American Journal of Ophthalmology

Volumn 129, Issue 2, 2000, Pages 144-150

  Giasson, Claude J ^a,b   Nguyen, Tuan Quynh Tram ^a,b   Boisjoly, Hélène M ^a,b   Lesk, Mark R ^a,b   Amyot, Marcel ^a,b   Charest, Manon ^a  

^a Guy Bernier Research Centre   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DORZOLAMIDE;

ADULT; AGED; ARTICLE; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA EDEMA; CORNEA THICKNESS; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAOCULAR HYPERTENSION; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARBONIC ANHYDRASE INHIBITORS; CELL COUNT; CONTACT LENSES; CORNEA; CORNEAL EDEMA; DOUBLE-BLIND METHOD; ENDOTHELIUM, CORNEAL; FEMALE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; SULFONAMIDES; THIOPHENES; TONOMETRY, OCULAR;

EID: 0033962748     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(99)00274-3     Document Type: Article

References (32)

1. Maren T.H. The development of topical carbonic anhydrase inhibitors. J Glaucoma. 4:1995;49-62.
2. Maren T.H. The development of ideas concerning the role of carbonic anhydrase in the secretion of aqueous humor relation to the treatment of glaucoma . Drance S.M., Neufeld A.H. Glaucoma applied pharmacology in medical treatment . 1984;325-355 Grune and Stratton, New York.
3. Hodson S., Miller F. The bicarbonate pump ion in the endothelium which regulates the hydration of rabbit cornea. J Physiol. 263:1976;563-577.
4. 3- fluxes on electrical potential and fluid transport across the rabbit corneal endothelium. Curr Eye Res 1982/3;2:183-186.
5. Wistrand P.J., Schenholm M., Lönnerholm G. Carbonic isoenzymes CAI and CaII in the human eye. Invest Ophthalmol Vis Sci. 27:1986;419-428.
6. Terashima H., Suzuki K., Kato K., Sugai N. Membrane-bound carbonic anhydrase activity in the rat corneal endothelium and retina. Jpn J Ophthalmol. 40:1996;142-153.
7. Ridderstrale Y., Wistrand P.J., Brechue W.F. Membrane-associated CA activity in the eye of the CAII-deficient mouse. Invest Ophthalmol Vis Sci. 35:1994;2577-2584.
8. Schwam C.F., Homnick C.F., Michelson S.R., et al. Identification and partial purification of a sodium dodecyl sulfate resistant carbonic anhydrase activity from the rabbit ciliary process. ARVO abstracts. Invest Ophthalmol Vis Sci. 34:(suppl 4):1993;930.
9. Wistrand P.J. Distribution and function of carbonic anhydrase (CA) isoenzymes in the human eye relevance for the design of topical CA inhibitors . Exp Eye Res. 55:(suppl 1):1992;S185.
10. Pfeiffer N. Dorzolamide development and clinical application of a topical carbonic anhydrase inhibitor . Surv Ophthalmol. 42:1997;137-151.
11. Nielsen C.B. The effect of carbonic anhydrase inhibition on central corneal thickness after cataract extraction. Acta Ophtalmol. 58:1980;985-990.
12. Becker B. The mechanism of the fall in intraocular pressure induced by the carbonic anhydrase inhibitor Diamox. Am J Ophtalmol. 39:1954;177-184.
13. Brechue W.F., Maren T.H. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion. Exp Eye Res. 57:1993;67-78.
14. Schoenwald R.D., Deshpande G.S., Rethwisch D.G., Barfknecht C.F. Penetration into the anterior chamber via the conjunctival/scleral pathway. J Ocul Pharmacol Ther. 13:1997;41-59.
15. Kuang K., Xu M., Koniarek J.P., Fischbarg J. Effects of ambient bicarbonate, phosphate and carbonic anhydrase inhibitors on fluid transport across rabbit corneal endothelium. Exp Eye Res. 50:1990;487-493.
16. Fischbarg J., Lim J.J. Role of cations, anions and carbonic anhydrase in fluid transport across the rabbit corneal endothelium. J Physiol. 241:1974;647-675.
17. Konowal A., Morrison J.C., Brown S.V.L., et al. Irreversible corneal decompensation in patients treated with topical dorzolamide. Am J Ophthalmol. 127:1999;403-406.
18. Herndon L.W., Choudhri S.A., Cox T., et al. Central corneal thickness in normal glaucomatous and ocular hypertensive eyes. Arch Ophthalmol. 115:1997;1137-1141.
19. Wilkerson M., Cyrlin M., Lippa E.A., et al. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor. Arch Ophthalmol. 111:1993;1343-1350.
20. Kaminski S., Hommer A., Koyuncu D., Biowski R., Barisani T., Baumgartner I. Influence of dorzolamide on corneal thickness, endothelial cell count and corneal sensibility. Acta Ophthalmol Scand. 76:1998;78-79.
21. Lass J.H., Khosrof S.A., Laurence J.K., Horwitz B., Ghosh K., Adamsons I. A double-masked, randomized, 1-year study comparing the corneal effects of dorzolamide, timolol, and betaxolol Dorzolamide Corneal Effects Study Group . Arch Ophthalmol. 116:1998;1003-1010.
22. Egan C.A., Hodge D.O., McLaren J.W., Bourne W.M. Effect of dorzolamide on corneal endothelial function in normal human eyes. Invest Ophthalmol Vis Sci. 39:1998;23-29.
23. Gagnon M.M., Boisjoly H.M., Brunette I., Charest M., Amyot M. Corneal endothelial cell density in glaucoma. Cornea. 16:1997;314-318.
24. Weston B.C., Bourne W.M., Polse K.A., Hodge D.O. Corneal hydration control in diabetes mellitus. Invest Ophthalmol Vis Sci. 36:1995;586-595.
25. Polse K.A., Brand R., Mandell R., Vastine D., Demartini D., Flom R. Age differences in corneal hydration control. Invest Ophthalmol Vis Sci. 30:1989;392-399.
26. Mandell R., Polse K.A., Brand R., Vastine D., Demartini D., Flom R. Corneal hydration control in Fuch's dystrophy. Invest Ophthalmol Vis Sci. 30:1989;845-852.
27. Bourne W.M., Nelson L.R., Hodge D.O. Central corneal endothelial cell changes over a ten-year period. Invest Ophthalmol Vis Sci. 38:1997;779-782.
28. Bonanno J.A., Srinivas S.P., Brown M. Effect of acetazolamide on intracellular pH and bicarbonate transport in bovine corneal endothelium. Exp Eye Res. 60:1995;425-434.
29. Edelhauser H.F., Maren T.H. Permeability of human cornea and sclera to sulfonamides carbonic anhydrase inhibitors. Arch Ophthalmol. 106:1988;1110-1115.
30. Sugrue M.F. The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor. J Ocular Pharmacol Ther. 12:1996;363-376.
31. 3- transport in cultured corneal endothelial cells. ARVO abstracts. Invest Ophthalmol Vis Sci. 39:(suppl 4):1998;S930.
32. Conroy C.W., Maren T.H. The effect of temperature on the binding of sulfonamides to carbonic anhydrase isoenzymes I, II, and IV. Mol Pharmacol. 48:1995;486-491.